Table 5 of Hou, Mol Vis 2008; 14:2597-2603.


Table 5. Stratification analysis for HLA-DRw53 and SUMO4 polymorphisms and the comparison of frequencies of SUMO4 allele and genotype in HLA-DRw53+ patients versus HLA-DRw53+ controls and HLA-DRw53- patients versus HLA-DRw53- controls.



SNPs


Genotype
allele
HLA-DRw53+
Patients
n=203 (%)
HLA-DRw53+
Controls
n=193 (%)


p value


pca value
HLA-DRw53-
Patients
n=28 (%)
HLA-DRw53-
Controls
n=109 (%)


p value


pca value
−847 G→A GG 13 (6.5) 20 (10.5) 0.368 NSb 3 (11.1) 10 (9.4) 0.200 NS
AG 91 (45.7) 83 (43.7)     13 (48.1) 33 (31.1)

AA 95 (47.7) 87 (45.8)     11 (40.7) 63 (59.4)

G 117 (29.4) 123 (32.4) 0.370 NS 19 (35.2) 53 (25.0) 0.133 NS
A 281 (70.6) 257 (67.6)     35 (64.8) 159 (75.0)

−504 A→G AA 43 (21.7) 43 (22.6) 0.742 NS 11 (40.8) 23 (21.5) 0.114 NS
AG 97 (49.0) 98 (51.6)     10 (37.0) 48 (44.9)

GG 58 (29.3) 49 (25.8)     6 (22.2) 36 (33.6)

A 183 (46.2) 184 (48.4) 0.538 NS 32 (59.3) 94 (43.9) 0.044 NS
G 213 (53.8) 196 (51.6)     22 (40.7) 120 (56.1)

+163 A→G AA 96 (47.5) 83 (43.0) 0.590 NS 11 (39.3) 62 (56.9) 0.216 NS
AG 93 (46.0) 94 (48.7)     14 (50.0) 36 (33.0)

GG 13 (6.4) 16 (8.3)     3 (10.7) 11 (10.1)

A 285 (70.5) 260 (67.4) 0.333 NS 36 (64.3) 160 (73.4) 0.178 NS
G 119 (29.5) 126 (32.6)     20 (35.7) 58 (26.6)

+438 C→T CC 95 (47.3) 82 (42.5) 0.035 NS 12 (42.9) 53 (48.6) 0.613 NS
CT 95 (47.3) 86 (44.6)     12 (42.9) 36 (33.0)

TT 11 (5.5) 25 (13.0)     4 (14.3) 20 (18.3)

C 285 (70.9) 250 (64.8) 0.065 NS 36 (64.3) 142 (65.1) 0.905 NS
T 117 (29.1) 136 (35.2)     20 (35.7) 76 (34.9)